Business

The Power Play by The Market Herald Releases New Interviews with Propel Holdings, Else Nutrition, Mullen Group, Pan American Energy and Nextech AR Solutions Discussing Their Latest News

VANCOUVER, BC / ACCESSWIRE / February 9, 2023 / The Power Play by The Market Herald has announce...

articleMullen Group Ltd.February 9, 20233/company/mullen-group-ltd/news/the-power-play-by-the-market-herald-releases-new-interviews-with-propel-holdings-else-nutrition-mullen-group-pan-american-energy-and-nextech-ar-solutions-discussing-their-latest-news
The Power Play by The Market Herald Releases New Interviews with Propel Holdings, Else Nutrition, Mullen Group, Pan American Energy and Nextech AR Solutions Discussing Their Latest News

About this update from Mullen Group Ltd.

[{"type":"text","content":"The Power Play by The Market Herald Releases New Interviews with Propel Holdings, Else Nutrition, Mullen Group, Pan American Energy and Nextech AR Solutions Discussing Their Latest NewsVANCOUVER, BC / ACCESSWIRE / February 9, 2023 / The Power Play by The Market Herald has announced the release of new interviews with Propel Holdings, Else Nutrition, Mullen Group, Pan American Energy and Nextech AR Solutions discussing their latest news.The Power Play by The Market Herald provides investors with a quick snapshot of what they need to know about the company's latest press release through exclusive insights and interviews with company executives.Propel Holdings (TSX:PRL) launches Fora Credit Propel (PRL) has launched Fora Credit, an online credit solution for underserved Canadians. Fora enables online applications for personal lines of credit up to C$10,000. The solution is intended to improve the lives of the nearly 25 per cent of Canadians that are either unserved or underserved in the credit market, according to a TransUnion study. CEO Clive Kinross spoke with Coreena Robertson about the news.For the full interview with Clive Kinross and to learn about Propel, click here.Else Nutrition (TSX:BABY) granted IRB approval for infant growth clinical study protocol Else (BABY) has received Institutional Review Board (IRB) approval for its infant growth clinical study protocol. This is a key step toward the U.S. launch of Else's new plant-based infant formula, which will serve as an alternative to dairy and soy-based products. CEO Hamutal Yitzhak spoke with Coreena Robertson about the news.For the full interview with Hamutal Yitzhak and to learn about Else Nutrition, click here.Mullen Group (TSX:MTL) reports record 2022 financial results Mullen Group (MTL) reported its financial and operating results for the quarter and year ended December 31, 2022. The company earned record revenue of $2.0 billion, up 35.3 per cent due to incremental acquisition revenue, increases in fuel surcharge revenue, and general rate increases. Mullen Group's Senior Accounting Officer Carson Urlacher met with Coreena Robertson to discuss the results.For the full interview with Carson Urlacher and to learn about Mullen Group, click here.Pan American Energy (CSE:PNRG) mobilizes drill rig for phase 1 program at Horizon Lithium Project Pan American Energy (PNRG) has m...

More updates from Mullen Group Ltd.